A 52-year-old man receives 60 mL of 1% lidocaine for epidural anesthesia during lumbar spine surgery. Within 2 minutes, he develops perioral tingling, confusion, and a brief generalized tonic-clonic seizure. The seizure self-terminates after 30 seconds. Which investigation would be most helpful in determining the severity of CNS toxicity and guiding further management?

## Investigation of CNS Local Anesthetic Toxicity **Key Point:** Serum lidocaine concentration directly correlates with CNS toxicity severity and is the most useful investigation to guide management decisions and predict risk of progression to cardiovascular toxicity. ### Clinical Context: Lidocaine CNS Toxicity The patient received 600 mg of lidocaine (60 mL × 1% = 600 mg), which exceeds the safe limit of 4.5 mg/kg (assuming ~70 kg = 315 mg maximum). The rapid onset of CNS symptoms (perioral paresthesias → confusion → seizure) within 2 minutes is classic for local anesthetic toxicity. ### Correlation of Serum Lidocaine Levels with CNS Manifestations | Serum Concentration (µg/mL) | CNS Manifestation | Severity | |---|---|---| | **1–5** | Perioral numbness, tinnitus, restlessness | Mild | | **5–10** | Confusion, visual disturbances, muscle twitching | Moderate | | **10–15** | **Seizures** (as in this case) | Severe | | **>15** | Loss of consciousness, apnea | Critical | | **>20** | Cardiovascular collapse (bradycardia, hypotension, asystole) | Terminal | **High-Yield:** Lidocaine CNS toxicity typically occurs at lower serum concentrations (10–15 µg/mL) than cardiovascular toxicity (>20 µg/mL), giving a "window" for intervention. Serum level at the time of seizure helps determine: 1. Whether CV toxicity is imminent 2. Whether seizure recurrence is likely 3. Need for prolonged observation vs. lipid emulsion therapy ### Why Serum Lidocaine Level is Superior to Alternatives ```mermaid flowchart TD A[Suspected LA toxicity]:::outcome --> B[Serum LA concentration]:::action B --> C{Level interpretation}:::decision C -->|10-15 µg/mL| D[CNS toxicity confirmed<br/>CV toxicity risk: moderate]:::outcome C -->|>15 µg/mL| E[Severe CNS + CV risk<br/>Lipid emulsion indicated]:::urgent C -->|<10 µg/mL| F[Mild toxicity<br/>Supportive care + monitor]:::action D --> G[Guide resuscitation intensity]:::action E --> G F --> H[Discharge after observation]:::action ``` **Clinical Pearl:** The patient's seizure self-terminated, suggesting the serum level was in the 10–15 µg/mL range (severe CNS, pre-cardiovascular phase). A serum level at this moment would: - Confirm LAST diagnosis - Predict risk of CV collapse (if >15 µg/mL, initiate lipid emulsion prophylactically) - Guide duration of monitoring ### Why Other Investigations Are Inferior | Investigation | Why NOT first-line | |---|---| | **EEG** | Shows seizure activity but does NOT quantify toxin burden; does not guide therapy | | **CT scan** | Contraindicated in acute seizure unless head trauma suspected; delays treatment; non-diagnostic for LAST | | **CSF analysis** | Invasive, time-consuming, non-specific; does not measure local anesthetic concentration | **Mnemonic:** **LAST Severity = Serum Level** - **L**idocaine level (or bupivacaine) - **A**lerts to CV risk - **S**eizure prediction - **T**herapy titration